Syncom Formul.

{
  "main_header": {
    "sid": 831770,
    "name": "Syncom Formul.",
    "stock_name": "Syncom Formul.",
    "full_name": "Syncom Formulations (India) Ltd",
    "name_url": "stocks-analysis/syncom-formul",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "20.39",
    "chg": 0.59,
    "chgp": "2.98%",
    "dir": 1,
    "prev_price": "19.80",
    "mcapval": "1,916.66 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524470,
    "symbol": "SYNCOMF",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE312C01025",
    "curr_date": "Sep 22, 09:27 AM",
    "curr_time": "09:28 AM",
    "last_traded_at": "Sep 22, 09:27 AM IST",
    "bse_nse_vol": "61.05 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 22, 2026",
    "traded_date_str": "2026 09 22",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/syncom-formul-831770-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Syncom Formulations (India) Ltd Shows Bullish Momentum Amid Technical Upgrades",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-shows-bullish-momentum-amid-technical-upgrades-4199106",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SyncomFormulati_technicaldot_4199106.png",
        "date": "2026-09-21 08:02:52",
        "description": "Syncom Formulations (India) Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators and an upgrade in its MarketsMOJO rating from Sell to Hold. The pharmaceutical and biotechnology company’s shares have surged 6.49% in a single day, reflecting renewed investor confidence amid a broader positive technical trend."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-hold-4198804",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SyncomFormulati_mojoScore_4198804.png",
        "date": "2026-09-20 10:10:05",
        "description": "Syncom Formulations (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 20 September 2026, providing investors with the most recent and relevant data to assess the company’s prospects."
      },
      {
        "title": "Syncom Formulations (India) Ltd Technical Momentum Shifts Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-technical-momentum-shifts-amid-mixed-indicators-4194195",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SyncomFormulati_technicaldot_4194195.png",
        "date": "2026-09-16 08:07:09",
        "description": "Syncom Formulations (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in daily price performance, the stock’s longer-term technical indicators suggest cautious optimism for investors."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-hold-4188047",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SyncomFormulati_mojoScore_4188047.png",
        "date": "2026-09-09 10:10:04",
        "description": "Syncom Formulations (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 September 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Syncom Formulations Gains 5.65%: 5 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-gains-565-5-key-factors-driving-the-weeks-momentum-4183644",
        "imagepath": "",
        "date": "2026-09-05 15:04:14",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>31 Aug:</strong> Technical rating upgraded to Hold, shares surge on bullish momentum</p>\n                    <p><strong>2 Sep:</strong> New 52-week high at Rs.20.89 amid sustained gains</p>\n                    <p><strong>3 Sep:</strong> Hits another 52-week high at Rs.22.18 with exceptional volume spike</p>\n                    <p><strong>3 Sep:</strong> Valuation shifts to very expensive, signalling heightened price attractiveness</p>\n                    <p><strong>4 Sep:</strong> Week closes at Rs.20.56, consolidating recent gains</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><..."
      },
      {
        "title": "Syncom Formulations Sees Exceptional Volume Surge Amidst Sustained Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-sees-exceptional-volume-surge-amidst-sustained-gains-4180782",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SyncomFormulati_most_active_equities_by_volume_4180782.png",
        "date": "2026-09-03 10:00:14",
        "description": "Syncom Formulations (India) Ltd has emerged as one of the most actively traded stocks by volume on 3 September 2026, registering a remarkable surge in investor participation and sustained price appreciation. The pharmaceutical company’s shares have demonstrated robust momentum, supported by a significant increase in traded volumes and a notable upgrade in its mojo grade, signalling a potential shift in market sentiment."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Syncom Formulations (India) Ltd to 52-Week High of Rs 22.18",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-hits-new-52-week-high-at-rs2218-4180750",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SyncomFormulati_priceRelatedfactors_4180750.png",
        "date": "2026-09-03 09:54:23",
        "description": "With a sustained six-day rally culminating in a fresh 52-week high of Rs 22.18 on 3 Sep 2026, Syncom Formulations (India) Ltd has demonstrated remarkable price momentum, outpacing its sector and the broader market despite recent headwinds for the Sensex."
      },
      {
        "title": "Syncom Formulations Valuation Shifts Signal Heightened Price Attractiveness Amid Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-valuation-shifts-signal-heightened-price-attractiveness-amid-sector-dynamics-4180214",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SyncomFormulati_valuationdot_4180214.png",
        "date": "2026-09-03 08:01:13",
        "description": "Syncom Formulations (India) Ltd has witnessed a significant re-rating in its valuation metrics, moving from an expensive to a very expensive category. This shift comes alongside robust price appreciation and improved market sentiment, positioning the micro-cap pharmaceutical firm in a challenging valuation territory compared to its peers and historical averages."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Syncom Formulations (India) Ltd to 52-Week High of Rs 20.89",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-hits-new-52-week-high-at-rs2089-4179548",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SyncomFormulati_priceRelatedfactors_4179548.png",
        "date": "2026-09-02 10:05:22",
        "description": "Syncom Formulations (India) Ltd has surged to a fresh 52-week high of Rs 20.89 on 2 Sep 2026, marking a significant milestone after a sustained rally that has delivered 22.08% returns over the past year, comfortably outperforming the Sensex’s decline of 4.71% during the same period."
      }
    ],
    "total": 312,
    "sid": "831770",
    "stock_news_url": "https://www.marketsmojo.com/news/syncom-formulations-india-831770"
  },
  "announcements": [
    {
      "caption": "Corporate Announcement/Information Under Regulation 42 Of SEBI (LODR) Regulations 2015 Regarding Record Date.",
      "datetime": "18-Sep-2026",
      "details": "We are pleased to inform you that pursuant to the provision of regulation 42 of SEBI (LODR) regulation 2015 and section 91 of companies Act 2013 the \"Record Date\" has been fixed as Wednesday 23rd September 2026 for the purpose of determining the entitlement of members for the payment of dividend.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "08-Sep-2026",
      "details": "Submission of copy of newpaper clippings of notice of 38th Annual General Meeting (AGM) Remote E-Voting Record Date and other details.",
      "source": "BSE"
    },
    {
      "caption": "Reg. 34 (1) Annual Report.",
      "datetime": "07-Sep-2026",
      "details": "Submission of 38th Annual Report along with the Notice of Annual General Meeting to be held on Wednesday 30th September 2026 through Video Conferencing (VC)/ Other Audio Visual Means (OAVM) at 2:00 P.M. pursuant to Regulation 34(1) of SEBI (LODR) Regulations 2015.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has declared <strong>10%</strong> dividend, ex-date: 23 Sep 26",
          "dt": "2026-09-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>1:10</strong> stock split, ex-date: 19 Aug 13",
          "dt": "2013-08-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>5:2</strong> bonus issue, ex-date: 19 Aug 13",
          "dt": "2013-08-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>1:2</strong> rights issue, ex-date: 13 May 09",
          "dt": "2009-05-13",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Syncom Formulations (India) Ltd Shows Bullish Momentum Amid Technical Upgrades

2026-09-21 08:02:52

Syncom Formulations (India) Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators and an upgrade in its MarketsMOJO rating from Sell to Hold. The pharmaceutical and biotechnology company’s shares have surged 6.49% in a single day, reflecting renewed investor confidence amid a broader positive technical trend.

Read full news article

Syncom Formulations (India) Ltd is Rated Hold

2026-09-20 10:10:05

Syncom Formulations (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 20 September 2026, providing investors with the most recent and relevant data to assess the company’s prospects.

Read full news article

Syncom Formulations (India) Ltd Technical Momentum Shifts Amid Mixed Indicators

2026-09-16 08:07:09

Syncom Formulations (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in daily price performance, the stock’s longer-term technical indicators suggest cautious optimism for investors.

Read full news article

Syncom Formulations (India) Ltd is Rated Hold

2026-09-09 10:10:04

Syncom Formulations (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 September 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Syncom Formulations Gains 5.65%: 5 Key Factors Driving the Week’s Momentum

2026-09-05 15:04:14

Key Events This Week

31 Aug: Technical rating upgraded to Hold, shares surge on bullish momentum

2 Sep: New 52-week high at Rs.20.89 amid sustained gains

3 Sep: Hits another 52-week high at Rs.22.18 with exceptional volume spike

3 Sep: Valuation shifts to very expensive, signalling heightened price attractiveness

4 Sep: Week closes at Rs.20.56, consolidating recent gains

Week Open

<...

Read full news article

Syncom Formulations Sees Exceptional Volume Surge Amidst Sustained Gains

2026-09-03 10:00:14

Syncom Formulations (India) Ltd has emerged as one of the most actively traded stocks by volume on 3 September 2026, registering a remarkable surge in investor participation and sustained price appreciation. The pharmaceutical company’s shares have demonstrated robust momentum, supported by a significant increase in traded volumes and a notable upgrade in its mojo grade, signalling a potential shift in market sentiment.

Read full news article

Broad-Based Technical Strength Lifts Syncom Formulations (India) Ltd to 52-Week High of Rs 22.18

2026-09-03 09:54:23

With a sustained six-day rally culminating in a fresh 52-week high of Rs 22.18 on 3 Sep 2026, Syncom Formulations (India) Ltd has demonstrated remarkable price momentum, outpacing its sector and the broader market despite recent headwinds for the Sensex.

Read full news article

Syncom Formulations Valuation Shifts Signal Heightened Price Attractiveness Amid Sector Dynamics

2026-09-03 08:01:13

Syncom Formulations (India) Ltd has witnessed a significant re-rating in its valuation metrics, moving from an expensive to a very expensive category. This shift comes alongside robust price appreciation and improved market sentiment, positioning the micro-cap pharmaceutical firm in a challenging valuation territory compared to its peers and historical averages.

Read full news article

Broad-Based Technical Strength Lifts Syncom Formulations (India) Ltd to 52-Week High of Rs 20.89

2026-09-02 10:05:22

Syncom Formulations (India) Ltd has surged to a fresh 52-week high of Rs 20.89 on 2 Sep 2026, marking a significant milestone after a sustained rally that has delivered 22.08% returns over the past year, comfortably outperforming the Sensex’s decline of 4.71% during the same period.

Read full news article

View All News